Residency · Kansas City, MO
Sponsored by Prime South GME Consortium
Progressive pulmonary fibrosis: an expert group consensus statement.
The European respiratory journal · 2023 · 201 citations · Kevin Brown
Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report.
Chest · 2021 · 181 citations · Kevin Brown
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
American journal of respiratory and critical care medicine · 2024 · 84 citations · Kevin Brown
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
JAMA · 2023 · 120 citations · Kevin Brown
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
The European respiratory journal · 2023 · 68 citations · Kevin Brown
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
The European respiratory journal · 2022 · 87 citations ·
Towards the adoption of quantitative computed tomography in the management of interstitial lung disease.
European respiratory review : an official journal of the European Respiratory Society · 2024 · 34 citations · Kevin Brown
Algorithmic Approach to the Diagnosis of Organizing Pneumonia: A Correlation of Clinical, Radiologic, and Pathologic Features.
Chest · 2022 · 60 citations · Kevin Brown